Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
about
15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survivalRegulation of inflammation in cancer by eicosanoidsOXER1, a G protein-coupled oxoeicosatetraenoid receptor, mediates the survival-promoting effects of arachidonate 5-lipoxygenase in prostate cancer cellsEnhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acidInhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilonInhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissueAre all n-3 polyunsaturated fatty acids created equal?The effect of 15-lipoxygenase-1 expression on cancer cellsPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-25-Oxo-ETE and the OXE receptorBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid5-lipoxygenase antagonist therapy: a new approach towards targeted cancer chemotherapyThe eosinophil chemoattractant 5-oxo-ETE and the OXE receptorAlterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinomaProstate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New BiomarkersMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisEffect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinomaPotential use of lipoxygenase inhibitors for cancer chemoprevention.Metalloproteinase dependent reduction of cell surface cluster determinants upon the induction of apoptosis.Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk.The role of cyclooxygenase and lipoxygenase in cancer chemoprevention.Fatty acid oxidation and signaling in apoptosis.Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cellsInhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells.MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer.Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells.Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 inductionTargeting of cytosolic phospholipase A2α impedes cell cycle re-entry of quiescent prostate cancer cells.Adoption of a plant-based diet by patients with recurrent prostate cancer.Expression and function of fatty acid amide hydrolase in prostate cancer.Biological mediators of effect of diet and stress reduction on prostate cancer.Roles of Eicosanoids in Prostate Cancer.Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer.Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid.Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressivenessDuCLOX-2/5 inhibition: a promising target for cancer chemoprevention.
P2860
Q21134042-45DB7F7F-DAEA-4C51-B1BD-18FB6807B063Q24564308-1A412A99-45CD-4B1E-A601-9E47F30D29E8Q24617505-8D0A888B-B724-47BA-8E97-C862A5E4FA63Q24626940-62447C0C-BB29-4736-A0FA-7BF47EA81CCEQ24633521-E38B8F32-CFFD-4C15-8CBB-9E10A47A8BCAQ24643373-3B5B3E5A-A986-4527-BE0D-9840F3E61484Q24685466-ECDC405C-9A40-48B0-9D50-29CB786CE9D8Q27497371-486DE085-21C2-40A4-8045-9F0F38EF90DFQ28207278-91903726-3162-4952-A073-11B60359BB49Q28209990-08C1242B-1FED-4C67-B61D-E10E8D55E5EBQ28245381-62814ED4-B502-4488-8C2E-679FD4CF5B2AQ28252674-B2EE82DF-AD00-48BB-8D25-5FE0BD53CCC3Q28292415-EB510A8C-9606-47C9-A1D5-171ECA4429C7Q28298968-DCF8E7FD-37F1-4DE7-AD0A-41781CD35C1DQ28360358-936C1559-9433-4005-98E5-59E2D483DE16Q28550619-AD9FEEBE-F39E-4F12-916F-007BE8FC19FEQ28658683-83A6CB1E-2F55-4176-8C93-19CDA972D2D7Q30523968-CDD9CDD2-D1E8-4C02-962C-A450541B4025Q33744090-74FBD07E-2632-4867-BD63-08213E96FB52Q33867006-57CE26A2-7A32-4504-8571-98082206420AQ34075076-48F2982C-AB5F-4307-8DD5-5F42FAAEA15BQ34086914-FC121915-9BA7-4D82-8A3C-9C427CD65556Q34121447-5A4D545E-1473-4561-B0EE-213ED4383F30Q34153217-E4D430D4-6524-4F32-9DA6-B3138C8D58BDQ34658888-961D9035-2791-4983-8DAF-71F7BDAA0CDFQ34928897-CD201FBD-37FB-489E-A1D0-471512BCE490Q35061682-D3EB6705-8598-4AF0-A45A-CE47B16D18F0Q35103979-21464000-4C54-4672-9B75-F2B659B933E2Q35431448-72D08A4C-F1D0-43EA-9085-F0A4C8AFC37CQ35676885-66D7B413-6491-4B92-9121-CDDC824CA687Q35989598-0FE3FA47-5912-43D8-A6FE-49B88B8FC98FQ36544125-6AD24087-2DF0-4414-8060-703D04B3729EQ36552943-4B563563-653C-48A0-A8F7-D3F1C0D012A6Q36901770-AA25DA6B-5F4A-4968-A23C-808E8793F12CQ37322592-1F5703C1-AF1B-4FB7-9987-3C47458B5139Q37592857-DB216E54-97E3-4660-8433-638A48AAB0FBQ37695659-1555F3D8-C961-4002-A4DE-8B0D5DC76C6DQ38237620-EE209573-2367-42E2-B854-EBA7190791CBQ38559278-8D59BF34-EA98-47FF-898F-F070DBE78DF0Q38936688-B617DDE9-57A5-4E7A-85AD-06DD85C80519
P2860
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@ast
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@en
type
label
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@ast
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@en
prefLabel
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@ast
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@en
P356
P1476
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase.
@en
P2093
P304
P356
10.1006/BBRC.1997.6799
P407
P577
1997-06-01T00:00:00Z